Chronic Pain After Amputation

NCT ID: NCT00006427

Last Updated: 2016-09-26

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE4

Total Enrollment

125 participants

Study Classification

INTERVENTIONAL

Study Start Date

1996-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This trial will test the effectiveness of amitriptyline in relieving chronic pain of adults that have had an amputation

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This double-masked placebo controlled trial will randomize patients (n=125) who are 6 months or more after amputation and have a 3 or more month history of pain to a daily dose of amitriptyline or a placebo for 6 weeks. Patients will receive a complete functional neurological examination by one of the study physicians or nurses masked to their treatment assignment. Study participants will also be interviewed by telephone to assess pain, pain interference with activities, physical and mental health, and number of health care visits for pain, at the beginning and end of the six-week trial and four months later.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Amputation, Traumatic Pain Postoperative Pain

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Amitriptyline

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Amputation six months ago or longer
* Pain for 3 months or longer

Exclusion Criteria

* History of cardiovascular disease, seizures, or glaucoma
* Currently taking antidepressant medications
* Currently hyperthyroid or taking thyroid medication
* Currently pregnant
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

Sponsor Role lead

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Lawrence Robinson, MD, Professor

Role: PRINCIPAL_INVESTIGATOR

University of Washington, Department of Rehabilitation

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Washington, Department of Rehabilitation Medicine

Seattle, Washington, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

References

Explore related publications, articles, or registry entries linked to this study.

Davis RW. Successful treatment for phantom pain. Orthopedics. 1993 Jun;16(6):691-5. doi: 10.3928/0147-7447-19930601-10.

Reference Type BACKGROUND
PMID: 8321759 (View on PubMed)

Onghena P, Van Houdenhove B. Antidepressant-induced analgesia in chronic non-malignant pain: a meta-analysis of 39 placebo-controlled studies. Pain. 1992 May;49(2):205-219. doi: 10.1016/0304-3959(92)90144-Z.

Reference Type BACKGROUND
PMID: 1535121 (View on PubMed)

Philipp M, Fickinger M. Psychotropic drugs in the management of chronic pain syndromes. Pharmacopsychiatry. 1993 Nov;26(6):221-34. doi: 10.1055/s-2007-1014359.

Reference Type BACKGROUND
PMID: 8127926 (View on PubMed)

Related Links

Access external resources that provide additional context or updates about the study.

http://depts.washington.edu/rehab/research/chronic.html

University of Washington, Department of Rehabilitation Medicine, Chronic Pain Study Website

http://www.nichd.nih.gov/

Click here for more information about the National Institute of Child Health and Human Development (NICHD).

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

P01HD033988

Identifier Type: NIH

Identifier Source: secondary_id

View Link

NICHD-0121

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Ketamine HCl Prolonged Release Oral Tablets for CRPS
NCT06419985 NOT_YET_RECRUITING PHASE2